easternhoogl.blogg.se

1. CURREN$Y PILOT TALK 3 OPENING CREDITS INSTRUMENTAL TRIAL
2. CURREN$Y PILOT TALK 3 OPENING CREDITS INSTRUMENTAL SERIES

He has also chaired the Educational Strategies Workshop of the Association of Medical School Microbiology And Immunology Chairs on behalf of the American Association of Medical Colleges (AAMC) and serves as one of the College of Dental Medicine’s representatives to the American Dental Education Association’s (ADEA) Commission on Change and Innovation in Dental Education. This effort was instrumental in serving the College of Dental Medicine during their recent self-study in evaluating the effectiveness of their curriculum and has led to process improvements in the formative and summative assessment of dental students. To this end he has explored using learning analytics to assess how students in a dental curriculum are mastering competency. Schmidt is also very active in the educational missions of the Colleges of Graduate Studies, Medicine and Dentistry at MUSC. Recent work has focused on the relationship between the population distribution of the human intestinal microbiome and the genesis of colorectal cancer, type II diabetes, NASH and necrotizing ulcerative colitis in a neonatal population.ĭr. This work has resulted in an issued US patent.Īdditionally, his laboratory has expertise in the molecular characterization of complex biofilms, principally those associated with mixed microbial communities including those of medical and dental significance. Much of the basic science work from the evaluation of the antimicrobial properties of copper led to recent efforts into the realm of dental materials where he with clinical colleagues appreciated the role that copper-iodide nanoparticles might serve in continuously limiting biofilm activity associated with dental restorations resulting in improved outcomes secondary to longevity enhancements of the dental materials in the oral environment. The results from this study were the basis of a talk he provided to TEDxCharleston in 2013.

CURREN$Y PILOT TALK 3 OPENING CREDITS INSTRUMENTAL TRIAL

Here in concert with a group of infectious disease specialists, infection control professionals, architects and engineers they are building on the success of a previous multi-center clinical trial where they established that by controlling burden in the built clinical environment through the introduction of the limited and targeted placement of solid copper alloys, they were able to significantly reduce HAI acquisition rates by 58%. This work directly compliments his efforts in leading an inter-institutional/ interdisciplinary team of professionals investigating the role that microbes associated with objects present in the built clinical environments play in this 150 billion dollar problem facing US healthcare.

CURREN$Y PILOT TALK 3 OPENING CREDITS INSTRUMENTAL SERIES

Oliver.ġ985 Ph.D., Indiana University, BloomingtonĬurrently, he is developing a series of comprehensive multi-center clinical trials that will evaluate the world’s first continuously active and non-leaching antimicrobial gloves for use in healthcare in order to assess their utility in limiting the acquisition of healthcare associated infections (HAI). 1985-1989 Postdoctoral Fellowship, State University of New York at Stony Brook, Research Associate in the laboratory of Donald B.